TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05415878

Intervention type: DEVICE
Group type: OTHER
Intervention: RCW design form
Description: Tall RCW= a knee high removable cast walker with an offloading insole~Short RCW= an ankle high (extending up the leg just past the ankle) removable cast walker with an offloading insole, paired with an external shoe lift to be used with a diabetic shoe on the contralateral limb

Intervention type: DEVICE
Group type: OTHER
Intervention: RCW design form
Description: Tall RCW= a knee high removable cast walker with an offloading insole~Short RCW= an ankle high (extending up the leg just past the ankle) removable cast walker with an offloading insole, paired with an external shoe lift to be used with a diabetic shoe on the contralateral limb
Study: NCT06046482

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magrolimab
Description: Given by IV (vein)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magrolimab
Description: Given by IV (vein)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cetuximab
Description: Given by IV (vein)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cetuximab
Description: Given by IV (vein)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: Given by IV (vein)
Study: NCT05420766

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Shortened Sleep
Description: In this experimental condition, children go to bed 90 minutes later than their typical bedtime during Week 2 of the 4-week protocol.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Stabilized sleep
Description: In this control condition, children go to bed at their usual time throughout the 4-week protocol.
Study: NCT06387615

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active cTBS
Description: Active stimulation

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Control stimulation
Study: NCT04076683

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Algodrep
Description: Algorithm computing the volume of blood to be transfused and the interval between apheresis which are necessary to maintain an individual objective of HbS percentage.
Study: NCT05747950

Intervention type: OTHER
Group type: OTHER
Intervention: Vibration
Description: Vibration is used as an alternative to physical exercise in various areas to increase muscle performance and flexibility, improve balance and proprioception, reduce spasticity and increase bone density.

Intervention type: OTHER
Group type: OTHER
Intervention: Modified Constraint-İnduced Movement Therapy
Description: Compulsory use therapy is a form of treatment in which the movements of the healthy side are prevented and the use of the weak side is encouraged in the stroke patient.

Intervention type: OTHER
Group type: OTHER
Intervention: Conventional Therapy
Description: Conventional exercises
Study: NCT03977779

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Placement of ARCHIMEDES fast biodegradable stent during the Endoscopic Retrograde CholoangioPancreatography
Description: The ARCHIMEDES Fast biodegradable pancreatic stent will be placed during the Endoscopic Retrograde CholoangioPancreatography
Study: NCT06464107

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PadKit™ from Preprogen
Description: The interlabial pad is classified as a Class 1 device by the FDA and the device is exempt from requiring a 510(k) approval.~The interlabial pad is worn for 4-6 consecutive hours and collects cells shed from the cervix and uterine cavity. The pad is then removed and placed in the smaller, inner tube that contains the transport solution. After replacing the lid securely, it is then carefully placed back inside the larger outer tube with the outer lid secured and returned to the original box. The entire box is placed in the polybag and mailed back to the lab for analysis.
Study: NCT06168214

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rabeprazloe+bismuth+amoxicillin+clarithromycin
Description: PBAC: 14D: PPI: Rabeprazole 10mg bid; B: bismuth potassium citrate240mg bid/ colloidal bismuth pectin 300mg bid/ colloidal bismuth tartrate 220mg bid; A:amoxicillin1000mg bid; C: clarithromycin 500mg bid.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan+amoxicillin+clarithromycin 14 days
Description: VAC14: 14D: V: vonoprazan 20mg bid; A: amoxicillin1000mg bid; C: clarithromycin 500mg bid.
Study: NCT06168214

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan+amoxicillin+clarithromycin 7 days
Description: VAC7: 7D: V: vonoprazan 20mg bid; A: amoxicillin1000mg bid; C: clarithromycin 500mg bid.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan+tetracycline+furazolidone 14 days
Description: VTF14: 14D: V: vonoprazan 20mg bid; T: tetracycline 500mg tid; F: furazolidone 100mg bid.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan+tetracycline+furazolidone 7 days
Description: VTF7: 7D: V: vonoprazan 20mg bid; T: tetracycline 500mg tid; F: furazolidone 100mg bid.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan+amoxicillin+furazolidone 7 days
Description: hVAF: 7D: V: vonoprazan 20mg bid; A: amoxicillin1000mg tid; F: furazolidone 100mg bid.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan+amoxicillin+tetracycline 14 days
Description: hVAT: 14D: V: vonoprazan 20mg bid; A: amoxicillin1000mg tid; T: tetracycline 500mg tid.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan+amoxicillin 7 days
Description: hVA7: 7D: V: vonoprazan 20mg bid; A: amoxicillin1000mg tid.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan+amoxicillin 14 days
Description: hVA14: 14D: V: vonoprazan 20mg bid; A: amoxicillin1000mg tid.
Study: NCT05398588

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cyriax Deep Friction Massage
Description: Hotpack : 10 min TENS : 20 min, High frequency(100 Hz pulse ), 3 days/week Kaltenborn mobilization: End range - Anterior, posterior and caudal glides :10 repetitions with 10 sec hold x 3 sets, 3 days/week Cyriax DFM on targeted muscles (Supraspinatus, Infraspinatus, subscapularis, Deltoid and Pectoralis) 3 minutes each muscle (15 mins in total ) x 1 set , 3 days / week

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Spencer Muscle energy technique
Description: Hotpack : 10 min TENS : 20 min, High frequency(100 Hz pulse ), 3 days/week Kaltenborn mobilization: End range - Anterior, posterior and caudal glides :10 repetitions with 10 sec hold x 3 sets, 3 days/week The Spencer technique will be applied in Abduction, External rotation and Internal rotation for targeting muscles Supraspinatus, Infraspinatus, subscapularis, Deltoid and Pectoralis.~10 repetitions x 3set , 3 days/week.
Study: NCT04327271

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text-based VMMC follow-up
Description: 2wT clients will receive automated daily texts from days 1-13. If a 2wT VMMC client responds that he suspects an AE, a VMMC nurse will exchange modifiable, scripted texts with clients to determine symptoms, frequency, and severity. Then, if deemed necessary, the client will be asked to return to clinic the following day or earlier. If 2wT patients do not respond to texts or return for any visit by day 14, they will be traced by SMS, phone or home visit. All study participants will be asked to come to the clinic for study-specific, Day 14 follow-up to review healing and verify adverse event reporting. At Day 21, we will implement a brief text-based survey with 2wT clients to ascertain complete healing, providing stronger inferences at study completion.
Study: NCT04841317

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Mobile technology intervention
Description: Home blood pressure cuff used by patients twice a week, with blood pressures transmitted to providers remotely
Study: NCT06196515

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Calcium hydroxide
Description: placement of intracanal medication for the three groups will be done after cleaning and shaping of the root canals and it will be left for one week.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nano calcium hydroxide
Description: placement of intracanal medication for the three groups will be done after cleaning and shaping of the root canals and it will be left for one week.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: nano calcium hydroxide
Description: placement of intracanal medication for the three groups will be done after cleaning and shaping of the root canals and it will be left for one week.
Study: NCT06195670

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Experimental
Description: SCRT: 5\*5Gy for 5 days, after a one-week rest, with fruquintinib plus sintilimab followed; Fruquintinib: qd po, 4mg/d, 2weeks on/1 week off, q3w; Sintilimab: intravenous infusion, 200mg, on day 1, q3w.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator
Description: Capecitabine: bid po, 1000mg/m², on days 1-14, q3w; Bevacizumab: intravenous infusion, 7.5mg/kg, on day 1, q3w.
Study: NCT05333809

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: an anti-PD-1 monoclonal antibody

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Disitamab vedotin
Description: HER2-ADC
Study: NCT04582071

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Description: Psychotherapy is a term that we use to describe the use of the psychological method to understand and improve an individual's well-being and mental health. The Principal Investigator of this study, a clinical psychologist will be leading each of the sessions.
Study: NCT05247320

Intervention type: DRUG
Intervention: Sotalol Injection
Description: Standard of care IV sotalol infusion for atrial arrhythmias

Intervention type: DRUG
Intervention: Sotalol Injection
Description: Standard of care IV sotalol infusion for atrial arrhythmias
Study: NCT05658991

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Retinal electrophysiology
Description: Retinal electrophysiology to assess retinal function before and with fasting during ramadan in both groups.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Retinal electrophysiology
Description: Retinal electrophysiology to assess retinal function before and with fasting during ramadan in both groups.
Study: NCT05705180

Intervention type: BIOLOGICAL
Intervention: recombinant adjuvanted zoster vaccine
Description: vaccination with recombinant adjuvantes zoster vaccine

Intervention type: BIOLOGICAL
Intervention: recombinant adjuvanted zoster vaccine
Description: vaccination with recombinant adjuvantes zoster vaccine
Study: NCT05519800

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Isomaltulose
Description: Diet will be supplemented with a beverage containing Isomaltulose as a carbohydrate source.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Maltodextrin
Description: Diet will be supplemented using a beverage containing Maltodextrin.
Study: NCT06188000

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Extra Virgin Olive Oil
Description: The patients was given extra virgin olive oil, an unrefined (not processed with chemicals or heat) for of olive oil

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Olive Oil
Description: The patients was given olive oil.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The patients was given empty capsule
Study: NCT06086249

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Regeneration using Injectable platelet-rich fibrin
Description: root canals of affected molars will be cleaned and shaped chemo-mechanically, after two weeks I-PRF will be applied.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Root canal treatment
Description: Conventional root canal treatment using gutta-percha obturation
Study: NCT05508256

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CE-marked Catheter Ablation
Description: Once patients have been randomized to the catheter ablation (CA) group, the ablation procedure must be performed within 4 weeks. CA will initially aim at pulmonary vein isolation.
Study: NCT06294353

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WELT-ED (CBT based DTx)
Description: The product delivers Cognitive Behavioral Therapy for Eating Disorders (CBT-ED) through a software interface (iOS and Android), designed to engage patients in a structured and interactive manner. It operates by analyzing patterns in the patient's lifestyle and eating data, identifying problematic behaviors associated with their eating disorder. Based on this analysis, the software sets daily learning objectives aimed at fostering positive cognitive and behavioral habits. By providing tailored guidance and support, the product seeks to assist patients in making sustainable changes, ultimately contributing to the improvement of eating disorder symptoms. This approach combines the principles of CBT-ED with the convenience and accessibility of digital technology, offering a personalized therapeutic experience to support patients in their recovery.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Standard Treatment
Description: In the control group, from screening/baseline (Visit 1) to 8 weeks (Visit 5), counseling and support therapy will be conducted at all visits. Participants can continue taking SSRI medications and other antipsychotic drugs that they were already taking for the treatment of eating disorders during the trial period. However, the intake of any additional antipsychotic drugs, other than those already being taken (including SSRIs), is prohibited during the trial period.
Study: NCT06526377

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Natrunix
Description: Natrunix is a monoclonal antibody preparation. Natrunix antibody is indistinguishable from a natural antibody isolated from a healthy human. Natrunix is expected to be the safest, most effective therapy for alleviating inflammatory pain and mitigating damage, mainly in the spine and sacroiliac joints, in AxSpA patients.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo
Study: NCT06489288

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ERAS protocol
Description: The ERAS process mainly includes removing the urethral catheter before the recovery of anesthesia, removing the abdominal drainage tube within 3 days after surgery, removing the nasogastric feeding tu
Study: NCT06442072

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: guided online self-help program
Description: 16 weeks of training and application of psychotherapeutic methods

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: guided online self-help program
Description: 16 weeks of training and application of psychotherapeutic methods
Study: NCT05901090

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: M-TAPA block
Description: Following sterile conditions for bilateral M-TAPA block application, the transducer was inserted on the chondrium in the sagittal plane at the 9-10th rib level. Subsequently, a deep angle was created with the probe for visualization of the underside of the costochondrium. The sonovisible needle tip was placed just below the chondrium and saline (5 ml) was injected for site confirmation. After the confirmation, 20 ml of 0.25% bupivacaine was administered for each group for a total of 40 ml of local anesthetic. Blocks were applied using an 80 mm sonovisible needle with a 6-10 MHz linear probe under the guidance of a portable ultrasound. M-TAPA block with the same standard technique and drug dose was applied to the contralateral side for each group of M-TAPA patients.
Study: NCT06442072

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: guided online self-help program
Description: 16 weeks of training and application of psychotherapeutic methods
Study: NCT06489288

Intervention type: OTHER
Group type: OTHER
Intervention: ERAS protocol
Description: The ERAS process mainly includes removing the urethral catheter before the recovery of anesthesia, removing the abdominal drainage tube within 3 days after surgery, removing the nasogastric feeding tu
Study: NCT05662644

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Minimally Invasive Surgery for Esophageal Cancer
Description: Assessment of minimally Invasive Surgery for Esophageal Cancer
Study: NCT06106841

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 400mg of TQB3909 tablets
Description: TQB3909 tablets 400mg, TQB3909 tablets is a B-cell lymphoma (BCL)-2 inhibitor.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 600mg of TQB3909 tablets
Description: TQB3909 tablets 600mg, TQB3909 tablets is a B-cell lymphoma (BCL)-2 inhibitor.
Study: NCT06174935

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.01% atropine ophthalmic drop
Description: 0.01% atropine ophthalmic drop will be applied daily to the affected eye
Study: NCT05921721

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EOS
Description: This modality simultaneously captures biplanar radiographs (anteroposterior and lateral images) through the whole-body slot scanning with patients in standing position with ultralow irradiation
Study: NCT05901090

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: TAP block
Description: After the necessary sterilization conditions were established, the linear ultrasound probe was sterilely coated and placed in the middle of the iliac crest with the end limit of the ribs. Starting with skin, the layers in descending order, subcutaneous adipose tissue, external oblique muscle, internal oblique muscle, transversus abdominis muscle, and peritoneum were identified. As the tip of the 80 mm sonovisible needle passed through the muscular layers and fascia, a fascial click was felt and the needle was advanced with ultrasound in a controlled manner. After receiving the second click sensation (passage of the fascia of the internal oblique muscle), the location of the needle was fixed and frequently aspirated and applied to the plane so that 20 ml of 0.25% bupivacaine was applied to each side. (40 ml in total)
Study: NCT04948996

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: El Buen Consejo Móvil- Group (EBCM-G)
Description: 1. Psycho-education and Information using a CBT toolbox approach.~2. Self-Assessment to track, label and describe moods by daily prompts to state or text level of mood on the mood tracker (termómetro de animo).~3. Symptom Identification and Management: after identifying a label for type of thinking from a pull-down list, a corresponding short 1-3-minute recorded strategy such as Thought Stopping, Increasing Pleasurable Activity, Mindfulness or Priming will be provided.~4. Monitoring of treatment engagement and response to treatment: Reminders to engage will include text messages and phone calls from the facilitator to encourage use of the app according to a scripted protocol.~Additionally, participants in the Group Intervention will be able to communicate with and respond to one another through the group chat rooms within the app.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: El Buen Consejo Móvil- Individual (EBCM-I)
Description: 1. Psycho-education and Information using a CBT toolbox approach.~2. Self-Assessment to track, label and describe moods by daily prompts to state or text level of mood on the mood tracker (termómetro de animo).~3. Symptom Identification and Management: after identifying a label for type of thinking from a pull-down list, a corresponding short 1-3-minute recorded strategy such as Thought Stopping, Increasing Pleasurable Activity, Mindfulness or Priming will be provided.~4. Monitoring of treatment engagement and response to treatment: Reminders to engage will include text messages and phone calls from the facilitator to encourage use of the app according to a scripted protocol.
Study: NCT05321186

Intervention type: PROCEDURE
Group type: OTHER
Intervention: minimally invasive spinopelvic fixation
Description: Bilateral percutaneous L4 and L5 pedicle screws will be placed under fluoroscopic guidance with Jamshidi needles, and these were will also be used the iliac fixation via percutaneous S2 alar iliac screws.~Cases presenting with significant instability, minimally invasive Transforaminal lumbar interbody fusion (MIS-TLIF) will be performed. Additionally, in cases with neurological deficit, posterior decompression will be performed.
Study: NCT06079502

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neuromuscular Electrical Stimulation
Description: A supervised program of intradialytic NMES of the quadriceps and calf muscles of both lower limbs with different phases, types and current intensity. The electrical stimulation program will included (total time, intensity, contraction-relaxation phase time): a toning program in the first two weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: resistive training program
Description: Part one: Warming up for 5 minutes in the form of lower limbs range of motion (active free) exercise from supine position.~Part two: The main part is the resistive training for quadriceps and calf muscles from supine position using weights in the form of sand bags for 20 min.~Part three: Cooling down for 5 minutes in the form of lower limbs range of motion (active free) exercise from supine position.~The training parameters:~The exercise training will be done during the first 2 hours of HD session using free leg weights. The patient will assume a supine lying position on the treatment plinth and perform the exercises for every lower limb separately while the other limb will be supported on the plinth by therapist or the patient himself. Resistance will be placed at the malleoli level in the distal third of the leg.